Enzo Nutraceuticals Ltd is an innovative science-based natural products company, producing and marketing, internationally, our key product: ENZOGENOL pine bark extract.
Enzo Nutraceuticals Ltd bases its product development on sound scientific principles, and produces safe and efficacious health-enhancing products using environmentally sound production methods.
FACTS
Company name: ENZO Nutraceuticals Limited
Head Office: Cnr Opatito Rd & Lee Ave, Paeroa 3600, New Zealand
Management
Director: Michael Giles
Director: Barry Giles
Managing Director: David Giles
Chief Science Officer: Dr. Matt Frevel
General Manager, Japan: Keiko Nakanishi
Established: 1998
Main Businesses
Manufacture and trade of Enzogenol® Pine Bark Extract
Research science on Enzogenol®
Sale and marketing of Enzogenol® food, supplement, and cosmetic products
Plant / Operation Facilities
Cnr Opatito Rd & Lee Ave, Paeroa 3600, New Zealand
Associated Companies
ENZO Bioactives Pty Ltd, Melbourne, Australia
Company History
1997
|
Process patent applications filed, Enzogenol trademark registered, Pilot production facility commissioned |
1998
|
ENZO Nutraceuticals Ltd founded, Production plant established, Enzogenol launched in New Zealand |
1999
|
Enzogenol launched internationally, US Process patent awarded |
2000
|
Distribution channels established in Singapore and USA |
2001
|
First clinical trial on Enzogenol commences, Enzogenol launch in Japan |
2002
|
UK office established, Research joint venture established with HortResearch Ltd, First peer reviewed publication on Enzogenol appears in print |
2003
|
Japan office established, Established Australia subsidiary, Three double-blind, controlled clinical trials commenced, Four additional patents filed |
2004
|
ENZO Nutraceuticals Ltd invited to exhibit at the 4th APEC Science Minister Conference, Enzogenol products launched in China, Two New Zealand patents granted |
2005
|
Head office move to Auckland |
2006
|
Commence building of new production facilities in Paeroa, New Zealand – ecologically designed model plant with ‘low-carbon footprint’, Completing new RCT on effects of Enzogenol on cognitive function, Filing new coginitive function patent for Enzogenol
|
2007
|
Finished construction of new plant and move to the new facilities, New Head Office,
|